Nextrove Successfully Completes Global Safety Database Conversion for Leading South Korean Pharmaceutical Company
March 2025 - Seoul, South Korea
About Nextrove
Nextrove leads the industry in Pharmacovigilance Professional Services and Solutions. Our unwavering mission, “Empowering Clients to Improve Patient Safety,” propels us on the path to realizing our vision of becoming the first choice for Life Sciences professional services and solutions, in service of our clients, partners, and, above all, the patients we ultimately serve.
www.nextrove.com
info@nextrove.com
+1 347 551 1700
Nextrove LLC.
116 Village Boulevard,
Princeton Forrestal Village, Suite 208
Princeton, NJ 08540, USA
Nextrove Korea LLC
Room 909-A-28, D-dong,
30 Songdomirae-ro,
Yeonsu-gu, Incheon,
South Korea 21990
Nextrove is proud to announce the successful completion of the Global Safety Database (GSD) conversion project from Arisg 7.4.6.2.5 to LSMV for one of South Korea’s top pharmaceutical companies, a leader in innovative drug development with 26+ drug pipelines and a strong presence in Hypertension, Dyslipidemia, and gastroesophageal reflux treatments across domestic and international markets.
Through a rigorous verification process, the Nextrove team ensured zero (0) bugs during end-to-end validation, delivering a seamless and efficient transition.
Client Testimonial
The client expressed high satisfaction with Nextrove’s expertise and commitment:
“It was our pleasure to have you and your team on this project, and we truly appreciate your support and hard work. Nextrove’s team provided prompt responses and effective solutions, ensuring the successful completion of the LSMV conversion. Every member of your team demonstrated excellent service quality, knowledge, skills, and commitment. We also learned a lot from this collaboration and look forward to working together on future projects.”
A Commitment to Excellence
This milestone underscores Nextrove’s expertise in pharmacovigilance technology transformation, ensuring compliance, efficiency, and enhanced safety data management for global pharmaceutical operations.
We extend our heartfelt thanks to our dedicated team for their meticulous execution and to our valued client for their trust and collaboration. We look forward to continuing our partnership and delivering more innovative solutions in the future.
